MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
14.3 M |
Market Cap[1] |
$ 17.4 M |
EBITDA (LTM) |
$ -55.6 M |
P/E (LTM) |
- |
P/S (LTM) |
0.141244 |
EPS (LTM) |
-1.57 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Repare Therapeutics
RPTX
|
- | - | $ 112 M | Nasdaq Global Select Market |  Canada |
 |
Sesen Bio
SESN
|
- | 7.29 % | $ 127 M | Nasdaq Global Select Market | USA |
 |
Windtree Therapeutics
WINT
|
- | - | $ 26.8 M | Nasdaq Global Select Market | USA |
 |
Trean Insurance Group
TIG
|
- | - | $ 316 M | Nasdaq Global Select Market | USA |
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
MEI Pharma
MEIP
|
- | 10.43 % | $ 20.5 M | Nasdaq Capital Market | USA |
 |
Palatin Technologies
PTN
|
- | - | $ 13 M | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ММЦБ
GEMA
|
- | - | - | MOEX | Russia |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | Russia |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.05 | -7.08 % | $ 6.61 M | Nasdaq Capital Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 0.98 | 0.51 % | $ 98.3 M | Nasdaq Global Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 11.82 | 3.96 % | $ 3.53 B | Nasdaq Global Select Market | Canada |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 58.02 | -0.58 % | $ 7.76 B | Nasdaq Global Select Market,SPB | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 55.95 | -1.2 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Celldex Therapeutics
CLDX
|
$ 29.25 | 0.97 % | $ 1.94 B | Nasdaq Global Select Market | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
$ 3.67 | 1.38 % | $ 44.8 M | Nasdaq Capital Market |  Israel |
 |
Jaguar Health
JAGX
|
$ 2.04 | -5.12 % | $ 4.76 M | Nasdaq Capital Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.55 | -0.58 % | $ 200 M | NYSE American | Israel |
 |
uniQure N.V.
QURE
|
$ 22.43 | -2.94 % | $ 1.29 B | Nasdaq Global Select Market | Niderland |
 |
Stoke Therapeutics
STOK
|
$ 25.04 | -2.57 % | $ 1.48 B | Nasdaq Global Select Market,SPB | USA |
 |
Xencor
XNCR
|
$ 25.18 | -2.55 % | $ 1.87 B | Nasdaq Global Select Market,SPB | USA |
 |
Annexon
ANNX
|
$ 3.75 | -1.57 % | $ 582 M | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.78 | -2.73 % | $ 2.93 M | NYSE American | Israel |
 |
Incyte Corporation
INCY
|
$ 115.71 | -1.04 % | $ 22.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 12.28 | -2.15 % | $ 14.8 B | Nasdaq Global Select Market |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.21 | -5.73 % | $ 741 M | Nasdaq Global Select Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 523.93 | -2.1 % | $ 134 B | Nasdaq Global Select Market,SPB | USA |
 |
Abeona Therapeutics
ABEO
|
$ 4.4 | -1.57 % | $ 233 M | Nasdaq Capital Market | USA |
 |
AbbVie
ABBV
|
$ 285.64 | 0.24 % | $ 505 B | NYSE,SPB | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.16 | -4.11 % | $ 259 K | NYSE American | USA |
 |
Akebia Therapeutics
AKBA
|
$ 0.57 | 0.84 % | $ 147 M | Nasdaq Global Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.2 | -0.24 % | $ 805 M | Nasdaq Global Select Market | Canada |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 19.73 | -2.86 % | $ 3.32 B | Nasdaq Global Select Market,SPB | USA |
 |
ADC Therapeutics SA
ADCT
|
$ 1.44 | -9.72 % | $ 183 M | NYSE |  Schweiz |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 25.51 | 4.51 % | $ 3.87 B | Nasdaq Global Select Market,SPB | USA |
 |
EyePoint Pharmaceuticals
EYPT
|
$ 0.4 | -5.51 % | $ 29.3 K | Nasdaq Global Market | USA |
 |
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 37.0 | -0.51 % | $ 2.14 B | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.